Flora Growth Corp. financial data

Symbol
FLGC on Nasdaq
Industry
Pharmaceutical Preparations
Location
3230 W. Commercial Boulevard, Suite 180, Fort Lauderdale, FL
State of incorporation
Ontario, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 125 %
Quick Ratio 49.8 %
Debt-to-equity 92.6 %
Return On Equity -192 % -23.1%
Return On Assets -54.3 %
Operating Margin -20.2 % +79.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.4M shares +95%
Common Stock, Shares, Outstanding 13.4M shares +94.9%
Entity Public Float 13.7M USD +31136264%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 12.3K shares +82.5%
Weighted Average Number of Shares Outstanding, Diluted 12.3K shares +82.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 69M USD +14.5%
Research and Development Expense 142K USD +47.9%
General and Administrative Expense 1.64M USD -29.2%
Operating Income (Loss) -13.9M USD +76.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.9M USD +78.1%
Income Tax Expense (Benefit) -338K USD +87%
Net Income (Loss) Attributable to Parent -14.9M USD +78.2%
Earnings Per Share, Basic -1.18 USD/shares +96.8%
Earnings Per Share, Diluted -1.18 USD/shares +96.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.13M USD +244%
Accounts Receivable, after Allowance for Credit Loss, Current 3.28M USD -32.4%
Inventory, Net 6.75M USD -22.3%
Assets, Current 21.4M USD -4.04%
Property, Plant and Equipment, Net 806K USD -15.2%
Operating Lease, Right-of-Use Asset 1.49M USD +37.2%
Intangible Assets, Net (Excluding Goodwill) 4.03M USD -29.5%
Goodwill 2.29M USD
Other Assets, Noncurrent 101K USD -61.6%
Assets 30.1M USD -1.3%
Accounts Payable, Current 4.62M USD -30.2%
Liabilities, Current 18.4M USD +3.12%
Deferred Income Tax Liabilities, Net 1.03M USD +96.6%
Operating Lease, Liability, Noncurrent 2.4M USD +128%
Other Liabilities, Noncurrent 942K USD
Liabilities 21.8M USD +7.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -132K USD +91.4%
Retained Earnings (Accumulated Deficit) -148M USD -7.21%
Stockholders' Equity Attributable to Parent 7.31M USD -33.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 8.27M USD -19.1%
Liabilities and Equity 30.1M USD -1.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.34M USD +69%
Net Cash Provided by (Used in) Financing Activities 1.19M USD
Net Cash Provided by (Used in) Investing Activities -88K USD +13.7%
Common Stock, Shares, Issued 13.4M shares +94.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -194K USD +95.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.16M USD +241%
Deferred Tax Assets, Valuation Allowance 36.2M USD +72.9%
Deferred Tax Assets, Gross 36.2M USD +52.1%
Operating Lease, Liability 3.2M USD +46.9%
Depreciation 200K USD 0%
Payments to Acquire Property, Plant, and Equipment 88K USD -13.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.5M USD +93.9%
Lessee, Operating Lease, Liability, to be Paid 3.94M USD +62.4%
Property, Plant and Equipment, Gross 1.18M USD +3.52%
Operating Lease, Liability, Current 801K USD -28.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 953K USD +141%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.04M USD +144%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +39%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 738K USD +199%
Lessee, Operating Lease, Liability, to be Paid, Year Three 741K USD +131%
Lessee, Operating Lease, Liability, to be Paid, Year Four 461K USD +860%
Operating Lease, Payments 1.43M USD +1.77%
Additional Paid in Capital 156M USD +3.29%
Amortization of Intangible Assets 757K USD -75%
Depreciation, Depletion and Amortization 74K USD -92.1%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 10K USD -98.5%